Yn dangos 106 i 120 o 452 canlyniadau
HCPC responds to COVID-19 Vaccines Delivery Plan
The UK Government published its COVID-19 Vaccines Delivery Plan on Monday 11th January.
CPD Week 2025 begins
Monday 3 March marks the start of the HCPC's first ever CPD Week. We will be showcasing resources, sharing good practice and publishing materials designed to support registrants with their CPD.
Naomi Nicholson joins HCPC as Executive Director of Professional Practice and Insight
HCPC is delighted to announce the appointment of Naomi Nicholson to the newly created role of Executive Director of Professional Practice and Insight.
New HCPC finance system
We are working on the implementation of the new finance system which will replace the current three systems we use to make payments.
The HCPC is looking for four new Council members
Council members play a key part in setting strategy and policy for the HCPC and ensuring that public protection is at the heart of everything that we do.
Physiotherapists: how to rejoin the Register if you’ve been removed
We want to get you back on the Register as soon as possible. Please follow these steps to make sure you've reapplied correctly.
HCPC and health regulators' joint statement supports reflective practice across healthcare
Nine healthcare regulators, including the HCPC, have signed a joint statement outlining the processes and advantages of good reflective practice
One month to go: Revised standards of conduct, performance and ethics
The revised standards of conduct, performance and ethics and revised guidance on social media are coming into effect on 1 September 2024. We encourage all registrants to ensure they are familiar with the changes.
HCPC response to DHSC healthcare regulation consultation
As we move forward with the wider programme of regulatory reform, we welcome this consultation to consider how the powers to introduce and remove professions from regulation might be used in the future.
Learning from our data – what 2020-21 taught us
Insights into the 2020-21 education dataset.
Reclassification of Gabapentin and Pregabalin
From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)
Recognising financial challenges currently facing the higher education sector
While we are not responsible for providing funding or direct financial support for the education providers or programmes we approve, we are keen to provide clarity and guidance where we can.
Deadline for expense claims is approaching
As we approach the end of the financial year, please submit all your outstanding expense claims by Sunday 31 March 2019
Performance review requirements 2023-24 - what to expect
We emailed education providers due their performance review in 2023-24 in late June. Providers who will undergo the process this year (2023-24) will have been given specific requirements and a key contact to work with at the HCPC.